The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor Nenad SarapaMargaret R. BrittoKourosh Parivar Clinical Trials 11 May 2005 Pages: 247 - 256
The effects of tramadol on static and dynamic pupillometry in healthy subjects—the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status Frank FliegertBurkhard KurthKarin Göhler Pharmacodynamics 20 May 2005 Pages: 257 - 266
Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers G. PeytavinC. GautranR. Farinotti Pharmacokinetics and Disposition 12 May 2005 Pages: 267 - 273
Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects Kyoung-Ah KimSae Ock OhJi-Young Park Pharmacokinetics and Disposition 25 May 2005 Pages: 275 - 280
Hyponatremia in elderly patients treated with desmopressin for nocturia: a review of a case series Torbjörn CallréusElisabet EkmanMorten Andersen Pharmacoepidemiology and Prescription 04 May 2005 Pages: 281 - 284
Press coverage and sales of Xenical in Sweden, 1998–2000 Fredrik BrounéusAnna DahlinBjörn Beermann Pharmacoepidemiology and Prescription 14 May 2005 Pages: 285 - 289
The impact of hospitalisation on the initiation and long-term use of benzodiazepines Rutger StuffkenRolf P. van HultenAntoine C. G. Egberts Pharmacoepidemiology and Prescription 14 May 2005 Pages: 291 - 295
Drug utilisation by children and adolescents with mental retardation: a population study H. TobiT. ScheersR. B. Minderaa Pharmacoepidemiology and Prescription 20 May 2005 Pages: 297 - 302
Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation E. C. G. van GeffenJ. G. HugtenburgA. C. G. Egberts Pharmacoepidemiology and Prescription 20 May 2005 Pages: 303 - 307
“Medicamentation” of society, non-diseases and non-medications: a point of view from social pharmacology T. B. Ngoundo MbongueA. SommetJ. L. Montastruc Short Communication 14 May 2005 Pages: 309 - 313
Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activity Craig R. LeeRoy L. HawkeJohn A. Pieper Letter to the Editors 04 May 2005 Pages: 315 - 316
Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients—a comment W. Zehngawa Letter to the Editors 13 May 2005 Pages: 317 - 317
The questionable use of antihypertensive drugs in the Italian Liguria Region in the year 2003 Luigi RobbianoAntonietta MartelliGiovanni Brambilla Letter to the Editors 13 May 2005 Pages: 319 - 320
Controlled withdrawal of selective serotonin reuptake inhibitors in elderly patients in nursing homes with no indication of depression—a commentary Juan MerloBo Gullberg Letter to the Editors 26 May 2005 Pages: 321 - 323